Cargando…

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

BACKGROUND: Coronavirus disease 2019 (Covid-19) has resulted in a global outbreak. Few existing targeted medications are available. Lianhuaqingwen (LH) capsule, a repurposed marketed Chinese herb product, has been proven effective for influenza. PURPOSE: To determine the safety and efficacy of LH ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ke, Guan, Wei-jie, Bi, Ying, Zhang, Wei, Li, Lanjuan, Zhang, Boli, Liu, Qingquan, Song, Yuanlin, Li, Xingwang, Duan, Zhongping, Zheng, Qingshan, Yang, Zifeng, Liang, Jingyi, Han, Mingfeng, Ruan, Lianguo, Wu, Chaomin, Zhang, Yunting, Jia, Zhen-hua, Zhong, Nan-shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier GmbH. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229744/ https://www.ncbi.nlm.nih.gov/pubmed/33867046 http://dx.doi.org/10.1016/j.phymed.2020.153242

Ejemplares similares

Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]
por: Hu, Ke, et al.
Publicado: (2022)

Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic
por: Liang, Chengyuan, et al.
Publicado: (2021)

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
por: Ding, Yuewen, et al.
Publicado: (2017)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Liang, et al.
Publicado: (2014)

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
por: Lan, Xiao-fang, et al.
Publicado: (2021)

A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
por: Zhang, Xiaobo, et al.
Publicado: (2021)

Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023)

Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)

The efficacy of combined therapy of qingfeiPaidu capsule and lianhuaqingwen capsule nursing interventions for hospitalized patients with COVID-19: A retrospective study of medical records
por: Li, Yan, et al.
Publicado: (2022)

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
por: Chen, Xiaofei, et al.
Publicado: (2021)

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
por: Runfeng, Li, et al.
Publicado: (2020)

Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
por: Liu, Ming, et al.
Publicado: (2021)

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
por: Fang, Jie, et al.
Publicado: (2020)

Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases
por: Shen, Pan, et al.
Publicado: (2021)

Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)
por: Fang, Jingai, et al.
Publicado: (2013)

A new perspective to improve the treatment of Lianhuaqingwen on COVID-19 and prevent the environmental health risk of medication
por: Gu, Wenwen, et al.
Publicado: (2022)

Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
por: Runfeng, Li, et al.
Publicado: (2021)

The clinical efficacy and safety research of Lianhuaqingwen (LHQW) in treatment of COVID-19: A systematic review and meta-analysis
por: Fang, Ling, et al.
Publicado: (2022)

Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials
por: Fan, Zheng, et al.
Publicado: (2021)

A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants
por: Dong, Yidan, et al.
Publicado: (2022)

New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment
por: Tianyu, Zhao, et al.
Publicado: (2021)

Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases
por: Yang, Chien-Chung, et al.
Publicado: (2021)

What Is the Relationship Between Body Mass Index, Sex Hormones, Leptin, and Irisin in Children and Adolescents? A Path Analysis
por: Zhang, Li, et al.
Publicado: (2022)

Association between body image dissatisfaction and body anthropometric indices among Chinese children and adolescents at different developmental stages
por: Wang, Yuanyuan, et al.
Publicado: (2022)

Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology
por: Wu, Leihong, et al.
Publicado: (2014)

Recent advances in poor HIV immune reconstitution: what will the future look like?
por: Zhang, Wenyuan, et al.
Publicado: (2023)

Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
por: Ma, Shiyu, et al.
Publicado: (2018)

An Association Between FNDC5, PGC-1α Genetic Variants and Obesity in Chinese Children: A Case-Control Study
por: Wang, Yuanyuan, et al.
Publicado: (2023)

The Chinese herb Styrax triggers pharmacokinetic herb-drug interactions via inhibiting intestinal CYP3A
por: Zhang, Feng, et al.
Publicado: (2022)

Repurposing antifungal drugs for cancer therapy
por: Weng, Ningna, et al.
Publicado: (2022)

Mining Important Herb Combinations of Traditional Chinese Medicine against Hypertension Based on the Symptom-Herb Network Combined with Network Pharmacology
por: Sun, Zhenhai, et al.
Publicado: (2022)

Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
por: Li, Lin, et al.
Publicado: (2022)

Network Analysis of the Herb–Drug Interactions of Citrus Herbs Inspired by the “Grapefruit Juice Effect”
por: Lü, Jintao, et al.
Publicado: (2022)

Mechanism of leptin-NPY on the onset of puberty in male offspring rats after androgen intervention during pregnancy
por: Liu, Jingqi, et al.
Publicado: (2023)

Medicinal Herbs and Their Active Compounds for Fatty Liver Diseases
por: Son, Chang Gue, et al.
Publicado: (2017)

Post COVID-19 burden: focus on the short-term condition
por: Yang, Fengwen, et al.
Publicado: (2022)

Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis
por: He, Shuaibing, et al.
Publicado: (2019)

Liu Shen Capsule Alters Airway Microbiota Composition and Metabolite Profiles in Healthy Humans
por: Wang, Xuerui, et al.
Publicado: (2022)

Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition
por: Liu, Mou-Ze, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i4kabmim361f7c3o5udlc5iefj